Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...

Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology

An agreement has been reached between Halozyme Therapeutics and Chugai Pharmaceutical where the latter paid a $25 million payment upfront to use...

Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector

Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become partners in leading digital technologies in the pharma sector across...

$30 million strategic agreement reached between Sanofi and DarioHealth

France- based Sanofi and DarioHealth have signed a five-year deal amounting to $30 million. The strategic agreement has a...

3D printed drugs to make customized care affordable through CurifyLabs & Natural Machines partnership

CurfiyLabs has set its sight on introducing affordable 3D printing in drug manufacturing with the help of Natural Machines. The launch date...

Hovione and Zerion collaborate to market the technology program Dispersome®

The market giant in particle engineering: Hovione has released a public statement that they would be joining forces with Zerion Pharmaceuticals to...

Softbank now has $5B stake in Roche for its ability to develop drugs using data

The Japanese multinational group, SoftBank Group Corp., has quietly invested $5 billion in Roche Holding AG, having high hopes with the company’s...

Most life sciences executives say digital delivery of drugs is the future of health

The world’s leading connectivity and provider of electronic solutions, Molex and, its medical device distribution subsidiary, Phillips-Mediaize,

Latest news

AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19

UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million....
- Advertisement -

Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion

United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a...

German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health

The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

How Artificial Intelligence is Transforming the Healthcare Industry

Artificial Intelligence (AI) has positively impacted many...

J&J, Allergan, Teva and Endo set to face a virtual trial over Opioid allegations

Until Covid-19, daily news focused on the involvement of pharmaceutical companies in the opioid drug addiction crisis,

NiKang Therapeutics raises $200m in Series C funding for new small molecules in oncology

Nikang therapeutics has raised $200 million in a Series C fundraising for the development of new smaller molecular entities to target difficult to treat cancer areas.